NCT00541684View on ClinicalTrials.gov

Health Assessment Study (0954-946)

PHASE3CompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

July 11, 2001

Primary Completion Date

January 23, 2003

Study Completion Date

January 23, 2003

Conditions
Hypertension
Interventions
DRUG

MK0954, /Duration of Treatment : 16 Weeks

DRUG

Comparator : atenolol /Duration of Treatment : 16 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00541684 - Health Assessment Study (0954-946) | Biotech Hunter | Biotech Hunter